🇺🇸 FDA
Pipeline program

Vatiquinone

PTC743-CNS-005-LSEP

Phase 3 small_molecule completed

Quick answer

Vatiquinone for Inherited Mitochondrial Disease is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PTC THERAPEUTICS, INC.
Indication
Inherited Mitochondrial Disease
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials